Leiden University Medical Center
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs by Stage
Trial / Program Status
Modality Mix
Indication Coverage
Program Types
Population Tags
Strong-Evidence Records
0 recordsChecked Records With Caveats
3 checked · 0 open checksIntratympanic methylprednisolone sodium succinate injections, 62.5 mg/mL, compared with placebo for control of vertigo attacks in Meniere disease, with hearing loss and tinnitus tracked as secondary outcomes.
Transtympanic sodium thiosulfate gel injected into one ear before cisplatin infusion to locally prevent cisplatin-induced sensorineural hearing loss while using the untreated contralateral ear as comparator.
Oral valganciclovir, a ganciclovir prodrug antiviral, evaluated to suppress congenital cytomegalovirus replication and reduce or stabilize CMV-associated sensorineural hearing-loss progression in infants and young children.